Skip to main content
. 2018 Oct 30;40(14):1149–1157. doi: 10.1093/eurheartj/ehy624

Table 1.

Sample characteristics by all-cause and cardiovascular mortality in MrOS

Alive (N = 1473) All-cause mortality (N = 1270) CVD mortality (N = 440)
Age (years), mean (SD) 74.3 (4.5) 78.8 (5.5) 79.2 (5.5)
BMI (kg/m2) 27.2 (3.6) 27.1 (4.1) 27.3 (3.9)
Race, n (%)
 Caucasian 1312 (89.1) 1177 (92.7) 411 (93.4)
 African American 54 (3.7) 38 (3.0) 8 (1.8)
 Other race 107 (7.3) 55 (4.3) 21 (4.8)
Alcohol, n (%)
 <1 glasses/week 660 (44.8) 608 (47.9) 218 (49.5)
 1–13 glasses/week 725 (49.2) 601 (47.3) 202 (45.9)
 14+ glasses/week 88 (6.0) 61 (4.8) 20 (4.6)
Congestive heart failure, n (%) 49 (3.3) 111 (8.7) 58 (13.2)
Cardiovascular disease (including congestive heart failure), n (%) 459 (31.2) 636 (50.1) 260 (59.1)
Hypertension, n (%) 658 (44.7) 703 (55.4) 272 (61.8)
Stroke, n (%) 34 (2.3) 68 (5.4) 27 (6.1)
Diabetes, n (%) 159 (10.8) 196 (15.4) 84 (19.1)
Renal failure, n (%) 5 (0.3) 21 (1.7) 7 (1.6)
Chronic obstructive pulmonary disease, n (%) 60 (4.1) 82 (6.5) 19 (4.3)
Smoking status, n (%)
 Never 613 (41.6) 484 (38.1) 164 (37.3)
 Former 836 (56.8) 758 (59.7) 271 (61.6)
 Current 24 (1.6) 28 (2.2) 5 (1.1)
Statin use, n (%) 631 (42.8) 499 (39.3) 196 (44.5)
Total sleep time (TST), n (%)
 >5–8 h 1221 (82.9) 970 (76.4) 336 (76.4)
 ≤5 h 224 (15.2) 257 (20.2) 92 (20.9)
 >8 h 28 (1.9) 43 (3.4) 12 (2.7)
Apnoea–hypopnoea index (events/h) 15.7 (13.9) 17.8 (14.8) 18.9 (15.1)
TST90 (%TST) 3.23 (7.76) 5.11 (10.9) 5.36 (10.4)
Hypoxic burden (%min/h) 53.3 (47.8) 64.3 (57.7) 72.7 (61.5)
 Q1 (≤20 %min/h), n (%) 324 (22.0) 225 (17.7) 64 (14.5)
 Q2 (20–34 %min/h), n (%) 304 (20.6) 248 (19.5) 77 (17.5)
 Q3 (34–53 %min/h), n (%) 324 (22.0) 224 (17.6) 71 (16.1)
 Q4 (53–88 %min/h), n (%) 283 (19.2) 270 (21.3) 100 (22.7)
 Q5 (>88 %min/h), n (%) 238 (16.2) 303 (23.9) 128 (29.1)